PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,587,423 | -39.7% | 258,538 | -38.6% | 0.01% | -44.4% |
| Q2 2023 | $2,634,358 | +31.2% | 420,824 | 0.0% | 0.01% | +28.6% |
| Q1 2023 | $2,007,330 | +52187.8% | 420,824 | -4.6% | 0.01% | -50.0% |
| Q4 2022 | $3,839 | -99.9% | 441,303 | -4.8% | 0.01% | -33.3% |
| Q3 2022 | $5,514,000 | -38.5% | 463,346 | -26.4% | 0.02% | -36.4% |
| Q2 2022 | $8,971,000 | -32.5% | 629,539 | -1.3% | 0.03% | -10.8% |
| Q1 2022 | $13,284,000 | +447.3% | 638,064 | +507.2% | 0.04% | +428.6% |
| Q4 2021 | $2,427,000 | +43.0% | 105,084 | +84.5% | 0.01% | +40.0% |
| Q3 2021 | $1,697,000 | -69.8% | 56,960 | -65.4% | 0.01% | -73.7% |
| Q2 2021 | $5,619,000 | – | 164,486 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |